JOSEP BORRELL
BY THE end of May, only 2.1 per cent of Africans have received at least one dose of a covid19 vaccine. We need to close the vaccination gap between advanced economies and developing countries to avoid what Tedros Ghebreyesus, head of the World Health Organization, has called 'vaccination apartheid.' Doing so is both morally right and in everyone's interest.
Therefore, we need global multilateral action to increase the production of vaccines and accelerate the roll-out worldwide. Since the beginning of the pandemic, this is the path chosen by the EU. It is now also the path defined by the G20 leaders at the Global Health Summit in Rome on May 21.
The pandemic is still killing thousands of people every day and at the current pace the whole world will not be vaccinated before 2023. Yet, a widely vaccinated world population is the only way to end the pandemic Otherwise, the multiplication of variants is likely to undermine the effectiveness of existing vaccines.
Vaccination is also a prerequisite for lifting the restrictions that are holding back our economies and freedoms. These restrictions penalise the whole world, but they weigh even more heavily on developing countries. Advanced countries can rely more on social mechanisms and economic policy levers to limit the impact of the pandemic on their citizens.
If the vaccination gap persists, it risks reversing the trend in recent decades of declining poverty and global inequalities. Such a negative dynamic would hold back economic activity and increase geopolitical tensions. The cost of inaction would for sure be much higher for advanced economies than what we collectively would have to spend to help vaccinate the whole world. Therefore, the EU welcomes the US$50 billion plan proposed by the International Monetary Fund in order to be able to vaccinate 40 per cent of the world population in 2021 and 60 per cent by mid-2022.
To achieve this goal, we need closely co-ordinated multilateral action. We must resist the threats posed by "vaccine diplomacy," linking the provision of vaccines to political goals, and "vaccine nationalism," reserving vaccines for oneself.
In contrast to others, the EU has rejected both since the beginning of the pandemic. Until now, we have been the only global actor that is vaccinating its own population while, at the same time, exporting large volumes of vaccines and contributing substantially to the vaccines roll-out in low-income countries. Europeans can be proud of this record.
In 2020, the EU supported the research and development of vaccines on a large scale and contributed significantly to the new generation of mRNA vaccines. The EU then became a major producer of covid19 vaccines with, according to the WHO, around 40 per cent of the doses used globally so far. The EU has also exported 240 million doses to 90 countries, which is about as much as we have used within the EU.
The EU with its member states and financial institutions - what we call 'Team Europe' - is also donating vaccines to neighbours i
